Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors

Clinical trial NCT01226030 · UNKNOWN

Trial details

NCT number: NCT01226030
Sponsor: Protgen Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2009-09-01
Primary completion: 2011-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.